Latest News

Syfe Launches Yield+ in Hong Kong to Make Locals' Savings Work Harder

The new HKD portfolio is designed for money set aside for 12 months or more, with no lock-in and no minimum investment HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Syfe, the Singapore-headquartered digital wealth platform managing over US$15 billion in assets across Asia-Pacific, today announced the...

2026-10-26 09:01 3325

Tin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf

SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- Ailytics , a vision AI startup that turns existing industrial CCTV into a real-time safety and operations layer, has raised US$7.4 million in a Series A led by Tin Men Capital. SEEDS, part of SG Growth Capital, Safie, Japan's larg...

2026-10-26 09:00 7256

Results of CARsgen's Satri-cel for Adjuvant Treatment for Gastric Cancer Presented at ESMO Congress 2026

SHANGHAI, Oct. 25, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the preliminary positive research results of the investigator-initiated trial (CT041-CG4010, NCT06857786) in China o...

2026-10-26 08:30 6119

Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity

- ASC39, an oral small molecule selective amylin receptor agonist, demonstrated eloralintide-like amylin selectivity and efficacy in preclinical models. - ASC39 demonstrated eloralintide-like selectivity for human amylin 1 receptor (hAMY1R) over human calcitonin receptor (hCTR) (40-fold), support...

2026-10-26 08:10 6480

26th Shanghai Fair Returns to Kuala Lumpur to Strengthen Trade and Cultural Ties

KUALA LUMPUR, Malaysia, Oct. 26, 2026 /PRNewswire/ -- The 26th Shanghai Fair Trade Show – Malaysia,organized by RCG International Convention & Exhibition Co. Limited, will take place on 16–17 November 2026 at the Malaysia International Trade and Exhibition Centre (MITEC), Kuala Lumpur, bringing ...

2026-10-26 08:00 2579

Antengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026

SHANGHAI and HONG KONG, Oct. 26, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-10-26 08:00 2646

uSMART and PIVOT Fintech Introduce GlobalSave Portfolios Balanced Strategy on FollowSmart

SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- uSMART Securities (Singapore) Pte. Ltd. ("uSMART") has announced the addition of thePIVOT- GlobalSave Portfolios Balanced Strategy to its FollowSmart platform. Managed by PIVOT Fintech Pte. Ltd. ("PIVOT"), the strategy is being made available through uSMAR...

2026-10-26 08:00 2128

RIMAN Connects Global Direct Selling Leaders with K-Beauty Innovation Through WFDSA World Congress and Jeju Experience Tour

* RIMAN participated as a Platinum Sponsor of the 18th WFDSA World Congress, highlighting its proprietary ingredients and R&D capabilities * The company hosted 24 direct selling industry representatives from nine countries for an exclusive brand experience on Jeju Island SEOUL, South Korea, O...

2026-10-26 08:00 4410

2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein

* The data showcased are from three Phase 1b clinical studies of IBI363/TAK-928 in first-line NSCLC, first-line G/GEJA, and immunotherapy-resistant lung adenocarcinoma, further supporting its potential clinical value across treatment settings. SAN FRANCISCO and SUZHOU, China, Oct. 25, 2026 /PR...

2026-10-26 08:00 4269

From Vietnam National Brand to Regional Giant: SUNHOUSE Secures Second Consecutive APEA Corporate Excellence Award

HANOI, Vietnam, Oct. 26, 2026 /PRNewswire/ -- At the Asia Pacific Enterprise Awards (APEA) 2026, SUNHOUSE was once again honored with the Asia Corporate Excellence Award. Marking its second consecutive victory, SUNHOUSE stands as the sole representative from Vietnam's home appliance sector featur...

2026-10-26 08:00 4348

DiDi Shareholders Overwhelmingly Back Hong Kong Relisting; Want Independent Director, Open Earnings Calls, and First Shareholder Meeting in Four Years, Survey Finds

A Heng Ren Partners survey this month finds at least 99.3% support on five key shareholder issues to boost shareholder value; shareholders want DiDi's board and management to respond with concrete action BOSTON, Oct. 26, 2026 /PRNewswire/ -- Heng Ren Partners LLC, an active asset manager whose f...

2026-10-26 07:00 6301

World Young Scientist Summit 2026 Opens in Wenzhou, Zhejiang

WENZHOU, China, Oct. 25, 2026 /PRNewswire/ -- A news report from China Daily: On October 24, the World Young Scientist Summit 2026 opened in Wenzhou, Zhejiang. The event is hosted by the China Association for Science and Technology (CAST), the Zhejiang Provincial People's Government, and the Worl...

2026-10-25 22:10 2183

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

* Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk of death (HR 0.69; 95% CI 0.54–0.89; one-sided P = 0.0021). * The 2-year OS rate was 54.1% vs 37.2%, an improvement of 16.9%; with a median follow-u...

2026-10-25 19:12 4911

The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine

* PFS was significantly prolonged: as assessed by BICR, the risk of disease progression or death was reduced by 51% (HR 0.49; 95% CI 0.36-0.65; P<0.0001 ), and median PFS was 15.0 months (95% CI 9.9-NE) and 5.7 months (95% CI 5.5-7.4) in the two groups, respectively. * Responses were more dur...

2026-10-25 18:44 5980

Ping An Highlights Green Development Initiatives at International Communication Seminar in Shenzhen Ahead of APEC 2026

HONG KONG and SHANGHAI, Oct. 25, 2026 /PRNewswire/ -- The Seminar on International Communication of Chinese and Foreign Enterprises' Green Development and Global Contributions was held at the Ping An Finance Center in Shenzhen on October 23. Hosted by the China Public Relations Association and c...

2026-10-25 14:06 9421

2026 ESMO | Innovent Announcement Phase 2 Data Presentation for IBI354 (HER2 ADC) In First-line Treatment of Breast Cancer

SAN FRANCISCO and SUZHOU, China, Oct. 25, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology, autoimmune, metabol...

2026-10-25 14:00 5467

2026 ESMO | Innovent Presented Phase 1 Study Data for IBI3001, a First-in-Class EGFR/B7H3 Bispecific ADC

SAN FRANCISCO and SUZHOU, China, Oct. 25, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology, autoimmune, metabol...

2026-10-25 14:00 5128

ST Engineering iDirect and MBSat Partner to Build Next-Generation Sovereign Connectivity Services Across Oman and the Middle East

Intuition ground system selected to support MBSat's planned 2027 service launch, enabling accelerated deployment, dynamic resource management and scalable service growth HERNDON, Va., Oct. 25, 2026 /PRNewswire/ -- ST Engineering iDirect today announced a strategic partnership with Mohammed Al Ba...

2026-10-25 13:00 4706

Zhejiang Wenda Pharma Announces Positive Results from Phase II Trial of Oral BET Inhibitor NHWD-870 HCl at the 2026 ESMO Annual Meeting

SHAOXING, China, Oct. 24, 2026 /PRNewswire/ -- At the 2026 ESMO Annual Meeting, Zhejiang Wenda Pharmaceutical Technology Co., Ltd. ("Wenda Pharma")  will publish the phase II clinical trial data for NHWD-870HCl, an oral BET inhibitor, in Chinese patients with advanced NUT carcinoma (NC). In this...

2026-10-25 09:00 5854

World Young Scientist Summit 2026 Opens in Wenzhou, Zhejiang

WENZHOU, China, Oct. 24, 2026 /PRNewswire/ -- This is a report by China Daily: On October 24, the World Young Scientist Summit 2026 opened in Wenzhou, Zhejiang. The event is hosted by the China Association for Science and Technology (CAST), the Zhejiang Provincial People's Government, and the Wor...

2026-10-24 22:37 3678
1 ... 35363738394041 ... 5531